Manufacturers looking to put into practice these solutions must provide sturdy validation data to reveal their equivalence to pharmacopoeial approaches. The WHO pointers stipulate that manufacturers will have to create and adhere to comprehensive routine maintenance schedules depending on equipment specs and usage designs. From the look on the waiting for link from Forum Profiles (6)